New study published online in the International Urogynecology Journal on January 21, shows UI symptom relief lasts for at least two years following eight weeks of Leva System-assisted pelvic floor muscle training (PFMT), which is a first-line treatment for incontinence.
New study published online in the International Urogynecology Journal on January 21, shows UI symptom relief lasts for at least two years following eight weeks of Leva System-assisted pelvic floor muscle training (PFMT), which is a first-line treatment for incontinence.
New study published online in the International Urogynecology Journal on January 21, shows UI symptom relief lasts for at least two years following eight weeks of Leva System-assisted pelvic floor muscle training (PFMT), which is a first-line treatment for incontinence.
New study published online in the International Urogynecology Journal on January 21, shows UI symptom relief lasts for at least two years following eight weeks of Leva System-assisted pelvic floor muscle training (PFMT), which is a first-line treatment for incontinence.
Axena Health, Inc. (Axena Health), a medical device company focused on female pelvic health, has launched a study to examine the barriers women faced while seeking treatment for urinary incontinence (UI) and fecal incontinence (FI).
Axena Health, Inc. (Axena Health), a women’s health medical device company focused on scalable treatments for female pelvic health, congratulates the researchers who received “Best Overall Abstract Presentation” from the International Urogynecological Association (IUGA) at its annual meeting in The Hague / The Netherlands on June 21-24, 2023
